| Quote | Spy PGNX NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Progenics Pharma Posts Q4 Loss of $0.02, Narrower than Views
PGNX Linked by StreetInsider - March 15, 09:15AM from (www.streetinsider.com) more ...
Progenics Announces Fourth Quarter and Year-End 2009 Financial Results
PGNX Linked by BusinessWire - March 15, 09:00AM from (www.businesswire.com) Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced its results of operations for the fourth quarter and year more ...
Progenics Announces Third Quarter 2009 Financial Results
PGNX Linked by BusinessWire - November 09, 08:00AM from (www.businesswire.com) Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced its results of operations for the third quarter and nine months more ...
Progenics Regains Worldwide Rights to RELISTOR Franchise
WYE PGNX Linked by BusinessWire - October 14, 07:00AM from (www.businesswire.com) Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that it has entered into an agreement with Wyeth Pharmaceuticals, more ...
Progenics Announces Promotion of Mark R. Baker to President and Appoints Him to Board of Directors
PGNX Linked by BusinessWire - September 16, 07:00AM from (www.businesswire.com) Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the promotion of Mark R. Baker to the newly created position more ...
Progenics Announces Second Quarter 2009 Financial Results
PGNX Linked by BusinessWire - August 06, 08:00AM from (www.businesswire.com) Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced its results of operations for the quarter and six months ended more ...
Progenics Announces First Quarter Financial Results
PGNX Linked by BusinessWire - May 11, 04:30PM from (www.businesswire.com) Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced its results of operations for the quarter ended March 31, more ...
Dendreon Up Big, but Other Cancer Drug Stocks Sector Mixed
JNJ PGNX CEGE VRTX GERN ALTH DNDN TELK AEZS KERX ANX MSHL Linked by tickerspy blog - April 14, 01:36PM from (www.tickerspy.com) A successful cancer study sent Dendreon (DNDN) flying Tuesday, taking some peers along for the ride. Dendreon announced more ...
Analyst upgrades, downgrades and initiations: WFMI, CCE, S, XOM, JPM ...
JPM XOM S FMER CCE NWL POWI PGNX WFMI SPWRA GBX SNDK MSM PAS PNFP CMP TNDM RDS.A Linked by BloggingStocks - March 16, 12:43PM from (www.pheedcontent.com) Analyst upgrades: KeyBanc upgraded Greenbrier (NYSE: GBX) to Buy from Hold as it believes the company has more ...
Progenics Pharmaceuticals "outperform," target price reduced
PGNX Linked by newratings - March 16, 11:43AM from (www.newratings.com) NEW YORK, March 16 (newratings.com) - Analysts at RBC Capital Markets reiterate their "outperform" rating on Progenics more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2010 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.
|
|